Peer-influenced content. Sources you trust. No registration required. This is HCN.
Pulmonology Advisor
A DNA methylation–based IgE score measured in infancy was associated with recurrent wheezing by age 3 across three pediatric cohorts.
Allergy & Immunology May 7th 2026
Conexiant
A small prospective study suggests inferior turbinate reduction may offer greater short‑term symptom relief than continued medical therapy in children with refractory allergic rhinitis, though evidence remains limited.
Allergy & Immunology April 22nd 2026
Vaccine Advisor
Investigators surmised that current influenza vaccination programs provide substantial protection but could be further improved by strategies that could mitigate repeat vaccination effects.
Allergy & Immunology April 9th 2026
Annals of Internal Medicine
The working group strongly recommended inhaled corticosteroids (ICS) and streamlined management of asthma by suggesting a combination of ICS and rapid-onset long-acting β-agonist as both reliever and controller agents and step-up therapy by increasing ICS and/or adding long-acting anticholinergic agents.
Allergy & Immunology March 16th 2026
Medical Professionals Reference (MPR)
“This device will become many patients’ primary epinephrine device because it removes the hurdle to administering epinephrine earlier in the anaphylactic process.” — Haley Overstreet, MD, Aspire Allergy & Sinus
Allergy & Immunology March 12th 2026
Consultant360
“Today’s approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.” – Iilun Murphy, MD, Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research